can you take semaglutide with afib For patients obesity and atrial fibrillation, GLP-1 receptor agonist drugs may be the weight loss approach that better addresses their arrhythmia, observational data suggested. https://www.medpagetoday.com/cardiology/arrhythmias/120327 FDA Clears Semaglutide For Cardiac

In response to the US study, Australian experts have weighed up the pros and cons of GLP-1RA use

Batterham, et al

Dietary modifications commonly occur with semaglutide treatment, both due to the medication's appetite-suppressing effects and patients' intentional efforts to maximize weight loss

The mean percentage change in body weight at week 68 was 14.9% in the semaglutide group vs 2.4% with placebo, for an estimated treatment difference of 12.4 percentage points (95% CI, 13.4 to 11.5)

Apart from modern technologies of targeted fat loss or surgical operations, no diet or weight loss drug can be directed to only one area of the body (for example, the face), so the same changes can happen in other areas we call this the Ozempic body